News

Should You Buy Eli Lilly Stock Before June 22?
Eli Lilly will be presenting data from studies on multiple GLP-1 drugs later this month. Eli Lilly (NYSE: LLY) stock hasn't ...
Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?
Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Both ...
Devdiscourse10h
Real-World Weight-Loss Results vs. Clinical Trials: The Reality of Obesity Medications
A new study shows weight-loss drugs, such as Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, yield lower weight reductions in ...
Stocktwits on MSN12h
Hims & Hers Stock Falls After Eli Lilly Rules Out Telehealth Tie-Up: Citi Calls It Aggressive Stance, Retail Turns Bearish
Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly ...
Health Rounds: Patients drop fewer pounds with weight-loss drugs in real world than in trials
By Nancy Lapid (Reuters) -People who take weight-loss drugs hoping to achieve the impressive results observed in large ...
UNILAD9h
Doctors explain exactly what could happen to your body if you try 'golden dose' hack for Ozempic and Mounjaro that could be fatal
Doctors have explained what the 'golden dosing' trend does to your body as Ozempic and Mounjaro rise in popularity for weight ...
Zacks.com on MSN5h
NVO Stock Gains After Parvus Asset Management Builds Stake
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.